Georgetown Lombardi Comprehensive Cancer Center

What Georgetown Lombardi Comprehensive Cancer Center does

Georgetown Lombardi Comprehensive Cancer Center, established in 1970, is Washington D.C.'s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center and operates as part of Georgetown University Medical Center in partnership with MedStar Health. The center delivers a four-part mission integrating research, teaching, patient care, and community service, with clinical operations delivered through MedStar Georgetown University Hospital (a U.S. News top 50-ranked cancer hospital) and community-facing programs through the National Capital Area NCORP and the Ralph Lauren Center for Cancer Prevention.

The center operates five specialized research centers (the Nina Hyde Center for Breast Cancer Research, the Ruesch Center for the Cure of Gastrointestinal Cancers, the Fisher Center for Hereditary Cancer and Clinical Genomics Research, the Lombardi Institute for Cancer and Aging Research, and the Innovation Center for Biomedical Informatics), supported by shared resources spanning genomics, bioinformatics, biostatistics, flow cytometry, imaging, and animal model facilities. Active research programs target the RAGE receptor mechanism in age-related breast cancer metastasis, microbiome contributions to early-onset colorectal cancer, and cancer immunotherapy, with pending patent applications covering RAGE-targeted therapies and a clinical trial evaluating the RAGE inhibitor TTP488 (azeliragon).

Revenue is derived from clinical care services delivered through MedStar Health, NIH/NCI research grants (including NCORP funding), philanthropy (Lombardi Women, Lombardi Gala, BellRinger, Men's Event, Avon Walk, Women & Wine), industry-sponsored clinical trials, and tuition from PhD/MS programs and postdoctoral training. Recent strategic actions include the 2022 establishment of the Ralph Lauren Center for Cancer Prevention, a $3 million Hyundai Hope On Wheels endowed chair in pediatric oncology (October 2024), renewed NCI designation (2026), and an active search for a new director to succeed Louis M. Weiner, who has led the institution since 2008.

Name

Georgetown Lombardi Comprehensive Cancer Center

Legal name

Georgetown Lombardi Comprehensive Cancer Center

Website

https://lombardi.georgetown.edu

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

251–500 employees

Short description

Georgetown Lombardi Comprehensive Cancer Center, established in 1970, is Washington D.C.'s only NCI-designated comprehensive cancer center. Part of Georgetown University Medical Center and partnered with MedStar Health, it conducts cancer research, delivers patient care, trains oncologists, and runs community prevention programs.

Ownership category

akta.pro rank

Product category

Academic Cancer Treatment and Research Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK), Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC)

Keywords

• Cancer research services
• Oncology clinical care
• Cancer clinical trials
• Biomedical research centers
• Oncology education programs

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Clinical Care Services: Georgetown Lombardi provides patient care through MedStar Georgetown University Hospital, generating revenue from medical services, procedures, and treatments delivered to cancer patients.
2. Research Grants and Philanthropy: The center receives significant funding from external grants (e.g., $3M Hyundai Hope On Wheels endowment for pediatric oncology) and charitable donations through events such as the Lombardi Gala, Lombardi Women, and BellRinger community fundraiser.
3. Education and Training Programs: Revenue from PhD and MS degree programs, postdoctoral training and fellowships, and educational outreach programs including the Young Scholars program.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Georgetown Lombardi Comprehensive Cancer Center is an NCI-designated comprehensive cancer center delivering cancer research, patient care, education, and community outreach. It operates specialized research centers (breast cancer, GI cancers, hereditary cancer, cancer and aging, biomedical informatics), runs clinical trials, provides clinical care through MedStar Georgetown University Hospital, and offers PhD/MS training and postdoctoral fellowships.

Product overview

Georgetown Lombardi Comprehensive Cancer Center is an NCI-designated comprehensive cancer center offering a comprehensive portfolio of cancer research, clinical care, and education services. The center operates multiple specialized research centers (Innovation Center for Biomedical Informatics, Fisher Center for Hereditary Cancer and Clinical Genomics Research, Nina Hyde Center for Breast Cancer Research, Ruesch Center for the Cure of Gastrointestinal Cancers, and Georgetown Lombardi Institute for Cancer and Aging Research), provides clinical care through MedStar Health partnership including the Capital Breast Care Center and Ralph Lauren Center for Cancer Prevention, offers clinical trials, maintains shared research resources (animal models, bioinformatics, biostatistics, flow cytometry, genomics, imaging, mass spectrometry), and provides education programs spanning PhD/MS degrees, postdoctoral training, and fellowships. The center hosts community events including BellRinger fundraising and Lombardi Women events.

Differentiator

Problem solved

Functional benefit

Products and services

• Innovation Center for Biomedical Informatics
• The Fisher Center for Hereditary Cancer and Clinical Genomics Research
• Nina Hyde Center for Breast Cancer Research
• The Ruesch Center for the Cure of Gastrointestinal Cancers
• Georgetown Lombardi Institute for Cancer and Aging Research
• Clinical Trials Program
• Education and Training Programs
• National Capital Area NCORP
• Ralph Lauren Center for Cancer Prevention
• Capital Breast Care Center

Quantifiable outcome

• RAGE inhibitor TTP488 demonstrated ability to reduce tumor cell invasiveness induced by aged mouse blood sera in preclinical models
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• Hackensack Meridian John Theurer Cancer CentercoreStrategic or Co-development Partner · 21 November 2025John Theurer Cancer Center at Hackensack University Medical Center is a leading research partner of the NCI-designated Lombardi Comprehensive Cancer Center at Georgetown University and is recognized as New Jersey's top-ranked cancer center. The partnership enables collaborative cancer research including presentation of studies at major conferences such as ASH Annual Meeting, spanning leukemia, lymphoma, myeloma, cell therapy, and AI-enabled diagnostics. JTCC presented 65 studies at ASH 2025.
• MedStar HealthcoreStrategic or Co-development PartnerGeorgetown Lombardi operates in partnership with MedStar Health, with care provided through MedStar Georgetown University Hospital, a U.S. News top 50-ranked hospital for cancer care. This partnership forms the primary clinical care delivery channel for the cancer center. Georgetown Lombardi also serves as part of the MedStar Georgetown Cancer Institute, a cancer service line serving patients in the Washington D.C. and Baltimore metropolitan areas.
• Georgetown University Medical CentercoreStrategic or Co-development PartnerGeorgetown Lombardi is part of Georgetown University Medical Center (GUMC), an internationally recognized academic health and science center with a four-part mission of research, teaching, service, and patient care. GUMC includes the School of Medicine, School of Nursing & Health Studies, Biomedical Graduate Research Organization, and Georgetown Lombardi Comprehensive Cancer Center.
• Ralph Lauren Center for Cancer PreventioncoreStrategic or Co-development PartnerThe Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi, established with a $25 million commitment from the Ralph Lauren Corporate Foundation, addresses disparities in cancer care in underserved communities in Washington D.C. Part of a five-center initiative recognizing White House Cancer Moonshot goals, the center provides free quality breast health care and navigation services to underserved and minority populations from the D.C. metropolitan area.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Johns Hopkins Sidney Kimmel Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center located in Baltimore, in the same Mid-Atlantic region as Georgetown Lombardi. A direct peer for clinical referrals, research collaboration, NCI grant funding, and oncology training, with comparable scope across breast, GI, and hereditary cancer research.
• Abramson Cancer Center (Penn Medicine): NCI-designated Comprehensive Cancer Center at the University of Pennsylvania, with strong translational research and clinical trials programs. Directly comparable as an NCI Comprehensive Cancer Center within an AMC-affiliated private research university.
• Memorial Sloan Kettering Cancer Center: One of the original NCI-designated Comprehensive Cancer Centers, providing integrated oncology research, treatment, and education in New York. Directly comparable as an NCI Comprehensive Cancer Center delivering the same four-part mission of research, teaching, patient care, and community service as Georgetown Lombardi.
• MD Anderson Cancer Center: The largest and one of the highest-ranked NCI-designated Comprehensive Cancer Centers globally, located in Houston. Directly comparable as an NCI Comprehensive Cancer Center with deep research, clinical trials, and education programs across all major cancer types.
• Dana-Farber Cancer Institute: NCI-designated Comprehensive Cancer Center affiliated with Harvard Medical School, focused on adult and pediatric cancer research and care. Directly comparable as an academic NCI Comprehensive Cancer Center with parallel mission in research, teaching, and patient care.
• UCSF Helen Diller Family Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center affiliated with UCSF, conducting research across cancer biology, population sciences, and clinical trials. Directly comparable as a university-based NCI Comprehensive Cancer Center with parallel structure to Georgetown Lombardi within an academic medical center.
• Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center in Seattle with strong focus on oncology research, including immunotherapy and bone marrow transplantation. Directly comparable as an NCI Comprehensive Cancer Center with significant research output and clinical trial activity.
• Yale Cancer Center: NCI-designated Comprehensive Cancer Center at Yale School of Medicine, conducting cancer research, treatment, and prevention. Comparable to Georgetown Lombardi as a smaller-scale NCI Comprehensive Cancer Center within a private research university with similar research and clinical care mission.
• Winship Cancer Institute of Emory University: NCI-designated Comprehensive Cancer Center at Emory University, serving the Southeastern U.S. Comparable in scope and structure to Georgetown Lombardi as an NCI Comprehensive Cancer Center conducting research across cancer types with strong clinical trial programs.

Regional players

• University of Virginia Cancer Center: NCI-designated Cancer Center (comprehensive status not held) at UVA in Charlottesville, serving Virginia and the Mid-Atlantic. A nearby regional peer competing with Georgetown Lombardi for the same catchment population, research talent, and NCI funding in the Washington-Virginia corridor.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/LombardiCancer
• Facebookfacebook.com/georgetownlombardi
• LinkedInlinkedin.com/company/georgetown-lombardi-comprehensive-cancer-center
• Instagraminstagram.com/georgetownlombardi

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Subsidiaries5 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Georgetown Lombardi Comprehensive Cancer Center